People living with HIV face a significant risk of severe COVID-19 and should be prioritised in national vaccination programmes, according to research presented on Thursday ahead of  the International AIDS Society’s (IAS) HIV Science conference which starts on Saturday. The World Health Organization (WHO) research looked at the data of 15,500 HIV positive people from […] Continue reading ->
Though new COVID-19 cases are down nearly 20% from last week in the Americas, many countries are experiencing a resurgence in infections, officials from the Pan American Health Organization (PAHO) announced at a press briefing on Wednesday.  Over 962,280 new cases were reported in the region in the past week, according to data from the […] Continue reading ->
WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading ->
CoronaVac, the Chinese vaccine developed by Sinovac, offers 83.5% protection against symptomatic COVID-19, according to interim data from a Phase 3 trial in Turkey published in the Lancet on Friday.  Meanwhile, a large study of the efficacy of the vaccine on 10.2 million Chileans found that it was 65.9% effective in preventing infection, 87,5% effective […] Continue reading ->
Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for   interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading ->
Though the Americas is the only World Health Organization (WHO) region that is reporting a slight decline in new COVID-19 cases this week, countries in Central and South America, Canada and Mexico are still experiencing rising rates of infection.  Over 1.1 million new COVID-19 cases were reported in the Americas over the last week, officials […] Continue reading ->
Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca.  Knowledge […] Continue reading ->